The Bioscience Association of West Virginia (BioWV) is that state’s official bioscience organization and is a part of the Council of State Bioscience Associations (CSBA). It serves West Virginia biotech companies with education and helps to increase public awareness of the biotechnology industry in the state.
Women in Bio (WIB) is a national organization dedicated to encouraging entrepreneurship and furthering the career development of women active in the life science industry. WIB is expanding nationally but has its roots in the Maryland/DC/Virginia corridor.
“We are thrilled to continue building strong alliances with these organizations,” said Mid-Atlantic Venture Association (MAVA) Executive Director Julia Spicer. “We can’t think of two more fitting state and national partners to welcome to this event, as each share the same deep commitment to bringing some of the best possible resources to their respective industry members and constituents.”
Now in its seventh year, Mid-Atlantic Bio is the only globally-focused, yet regionally-based, event to combine components of a bioscience industry convention with an investor conference under one roof. More than 800 national and international industry leaders, government representatives, executives, researchers, investors, entrepreneurs, and professional services firms will gather to promote networking, business expansion, and technical-knowledge sharing. Home to industry-critical regulatory and research agencies; federal policymaking; and business and scientific centers of excellence, the Mid-Atlantic is a unique center for the global bioscience industry.
Unparalleled Plenary Speakers
The conference brings some of the world’s most noted scientists and executives together all under one roof to provide important access for conference attendees to global thought-leaders. This year’s event offers a top tier line-up of plenary speakers, unique to this event, including:
§ John Castellani, President and CEO, PhRMA
§ John F. Crowley, JD, MBA, Chairman and CEO, Amicus Therapeutics
§ Frederick Frank, Vice Chairman, Peter J. Solomon Company
§ James Greenwood, President and CEO, BIO
§ Martine A. Rothblatt, PhD, JD, MBA, Chairman and CEO of United
§ Therapeutics Corporation
§ Joshua M. Sharfstein, MD, Principal Deputy Commissioner, U.S. Food
§ and Drug Administration
§ H. Thomas Watkins, President and CEO, Human Genome Sciences
Valued Timely and Topical Conference Sessions
Designed as a platform that brings together science, company builders, commercial interests and collaborators, capital sources, and federal and regulatory thought-leaders, the 2010 program includes a variety of important industry topics ranging from the latest in policy and regulatory matters, business and financing opportunities, and CEO War Stories to advances in science and technologyand showcases exciting companies from the biosciences field. A few of the highlighted sessions include:
§ Building a Workforce Culture Around Commercialization
§ Corporate Venture and Early Stage Partnerships
§ New Science Technologies: Regional Successes
§ Drugs and Devices: Reimbursement in a Post-Healthcare Reform World
§ Capital Eco-Systems: Formation and International Markets
§ An Insider’s View on Washington
§ Synthetic Biology Applications and Implications
§ Accessing the Regulatory Risk: Your Path to Approval
§ CEO War Stories: A Roundtable
Attendees Get a Close Look at the Latest Companies to Watch
Each year at Mid-Atlantic Bio, a select group of life science companies are chosen to present their respective stories before conference attendees, which include an audience of capital sources, including corporate business development professionals, peer scientists and company leaders, venture capitalists, angel investors, and various other qualified financing sources along with important industry professionals and potential strategic partners.
Mid-Atlantic Bio’s signature networking program, BioMatch, is designed specifically for the life sciences and biotech industries, and provides registered attendees access to advanced partnering software that
facilitates personalized, one-on-one meetings between the leading bioscience organizations and industry leaders.
Partial List of Conference Sponsors:
MD Biotechnology Center, MedImmune, Biotechnology Industry Organization, BioMed Realty Trust, Inc., BDO, Alexandria Real Estate Equities, Inc., Janelia Farms Research Campus of Howard Hughes Medical Institute, NIH
Federal Credit Union, George Mason University, Virginia Tech, James Madison University, Broad Oak Partners, H.I.G. BioVentures, CIT Gap Funds, Intersouth Partners, New Enterprises Associates, Oxford Finance,
TEDCO, Third Security, LLC
ABOUT MID-ATLANTIC BIO
The Mid-Atlantic Bio Conference, scheduled October 27-29, 2010, in Bethesda, Maryland, is co-hosted by the Tech Council of Maryland/MdBio (TCM/MdBio), the Mid-Atlantic Venture Association (MAVA), and the
Virginia Biotechnology Association (VaBIO). Mid-Atlantic Bio benefits from broad regional support from the investor and greater business communities, academic institutions, government agencies, and partnering
regional associations. For more information, or to register or sponsor, please visit